Mesoblast (ASX:MSB) has announced its financial results for FY14 and laid out a five-pronged strategy for commercialising its key regenerative medicine products.

Researchers have identified the specific portion of insulin that the immune system targets in type 1 diabetes, providing a potential pathway to improved treatments for the condition.

A US ITC judge has found in favour of ResMed (ASX:RMD) in the company's patent infringement action against China's BMC Medical, and has recommended an import ban.

Following on from a successful first-ever Tech Transfer Summit (TTS) Australia in 2013, the TTS Global Initiative and AusBiotech are pleased to confirm the Australian chapter will be returning to South Australia next week with the support of major partner BioSA.

Different DNA sequences in the telomeres of cancer cells may help unravel how these cells maintain their ability to endlessly multiply. [ + ]

Researchers at RTI International, in collaboration with The University of North Carolina at Chapel Hill, have developed a lung-on-chip microdevice for laboratory studies of respiratory challenges and therapeutics. [ + ]

An oceanographic research instrument, which will be part of the onboard equipment on the research vessel Investigator, has arrived at CSIRO in Hobart. [ + ]

The 2014 Australian Research Council (ARC) Australian Laureate Fellowships have been announced by Minister for Education Christopher Pyne. The scheme supports groundbreaking, internationally competitive research that builds Australia's research capacity. [ + ]

Former Mesoblast (ASX:MSB) CFO Jenni Pilcher has joined Alchemia (ASX:ACL), while former Novartis ANZ CFO 

Paul Hodgkinson will fill the vacant position at Mesoblast.

Orthocell's (ASX:OCC) autologous cell therapy Ortho-ATI improved grip strength in chronic tennis elbow patients by an average of 207% at 4.5 years post-treatment.

The inaugural Australian Science Industry Exchange event (ASiX) was held in Melbourne last week, with over 80 of the country's science sector business and technology leaders discussing the state of the industry and seeking to find better ways to do business.

Roche Sequencing and the Garvan Institute of Medical Research have announced a collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing. [ + ]

The Australian division of life science supplier Merck (Merck Millipore) is moving to a new head office. [ + ]

The inaugural Australian Science Industry Exchange event (ASiX) was held in Melbourne last week, with over 80 of the country's science sector business and technology leaders discussing the state of the industry and seeking to find better ways to do business. [ + ]

Laser physicists from the Australian National University (ANU) have found a way to make atomic-force microscope probes 20 times more sensitive. [ + ]